This inventor holds 1 USPTO granted patent. Top assignee: Alesta Therapeutics Bv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Brahmam Pujala and GCN2 Modulator Compounds.
Introduction
Brahmam Pujala is an inventor associated with New Delhi, India. His patent work includes research into compounds intended to modulate General Control Nondepressible 2 (GCN2), a target connected with certain disorders.
Latest Patents
Pujala is associated with one patent, titled “GCN2 Modulator Compounds.” The disclosure describes novel compounds of Formula (1), or salts thereof, with substituents defined in the patent. It discusses their potential use in treating, preventing, ameliorating, controlling, or reducing the risk of disorders associated with GCN2. The patent record lists 1 patent for Pujala.
Career Highlights
Pujala is associated with Alesta Therapeutics BV. His patent work reflects a focus on medicinal chemistry and the development of compounds with potential therapeutic applications.
Collaborations
The patent’s listed collaborators include Balaji Dashrath Sathe and Gonzalo Andrés Ureta Díaz. Their shared work concerns the disclosed GCN2 modulator compounds and their potential medical uses.
Conclusion
Brahmam Pujala’s patent activity centers on GCN2 modulator compounds, representing a contribution to research into potential treatments for disorders associated with this target.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile